Nabla, a Paris, France-based ambient AI assistant for healthcare practitioners, has closed an initial $24 million in Series B funding. Since its launch, Nabla has raised a total of $43 million.
The round was led by Cathay Innovation, with participation from ZEBOX Ventures.
Founded in 2015, Cathay Innovation is a venture capital firm based in San Francisco, California, which typically invests in Series B & C across Asia, North America, and Europe. The firm seeks to invest in consumer, enterprise, artificial intelligence & connectivity, digital health, energy, finance technology & insurance technology, the future of commerce, the future of work, mobility, and technology-based sectors.
Nabla Use of Funds
The company will use the funding to expand its presence across U.S. healthcare systems and enhance its ambient AI capabilities. Nabla aims to provide the most intuitive and reliable ambient AI assistant, supporting clinicians in various aspects of their work, including medical decision support.
Founded in 2018 by Alexandre Lebrun, Delphine Groll, and Martin Raison, Nabla is the developer of Nabla Copilot, an ambient AI that helps clinicians enjoy care again. AI-powered Nabla Copilot generates clinical notes in seconds from any encounter across all specialties, reducing practitioners' stress and improving patient care. Nabla Copilot's capabilities include AI-enabled medical coding identification and smooth EHR integrations.
Company: Nabla Technologies
Round: Series B
Funding Month: January 2024
Lead Investors: Cathay Innovation
Additional Investors: ZEBOX Ventures
Company Website: https://www.nabla.com/
Software Category: Healthcare AI Assistant